Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer

Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer

IntroductionTransurethral resection of bladder tumor with subsequent BCG immunotherapy is the current gold standard in the treatment of high risk and some medium-risk non-muscle invasive bladder cancer. Clinical factors like stage, grade, age and gender are well-know predictors of progression to mus...

Full description

Bibliographic Details
Main Authors: Mateusz Adamkiewicz, Piotr Bryniarski, Maksymilian Kowalik, Bartłomiej Burzyński, Paweł Rajwa, Andrzej Paradysz
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
lymphocyte-to-monocyte ratio
neutrophil-to-lymphocyte ratio
platelet-to-lymphocyte ratio
bladder cancer
transurethral resection of bladder tumor
Bacillus Calmet-Guiren immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.655000/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.655000/full

Similar Items